JP2019521154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521154A5 JP2019521154A5 JP2019501917A JP2019501917A JP2019521154A5 JP 2019521154 A5 JP2019521154 A5 JP 2019521154A5 JP 2019501917 A JP2019501917 A JP 2019501917A JP 2019501917 A JP2019501917 A JP 2019501917A JP 2019521154 A5 JP2019521154 A5 JP 2019521154A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- tumor
- dna molecule
- cell clone
- transformed cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022074854A JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16001550.9 | 2016-07-13 | ||
| EP16001550 | 2016-07-13 | ||
| PCT/EP2017/067590 WO2018011289A1 (en) | 2016-07-13 | 2017-07-12 | Process for the production of a dna vaccine for cancer immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022074854A Division JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521154A JP2019521154A (ja) | 2019-07-25 |
| JP2019521154A5 true JP2019521154A5 (https=) | 2020-08-20 |
| JP7098599B2 JP7098599B2 (ja) | 2022-07-11 |
Family
ID=56418345
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501917A Active JP7098599B2 (ja) | 2016-07-13 | 2017-07-12 | 癌免疫療法用のｄｎａワクチンの製造方法 |
| JP2022074854A Pending JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022074854A Pending JP2022097591A (ja) | 2016-07-13 | 2022-04-28 | 癌免疫療法用のｄｎａワクチンの製造方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10821163B2 (https=) |
| EP (1) | EP3484503A1 (https=) |
| JP (2) | JP7098599B2 (https=) |
| KR (3) | KR20190027834A (https=) |
| CN (1) | CN109475614A (https=) |
| AU (1) | AU2017295004B2 (https=) |
| BR (1) | BR112019000657A2 (https=) |
| CA (1) | CA3028549A1 (https=) |
| IL (1) | IL263568A (https=) |
| MX (1) | MX2019000415A (https=) |
| RU (1) | RU2019100079A (https=) |
| SG (1) | SG11201811258UA (https=) |
| WO (1) | WO2018011289A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018149982A1 (en) * | 2017-02-17 | 2018-08-23 | Vaximm Ag | Novel vegfr-2 targeting immunotherapy approach |
| EP3652318A1 (en) | 2017-07-11 | 2020-05-20 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| JP7340591B2 (ja) | 2018-07-11 | 2023-09-07 | アクティム・セラピューティクス・インコーポレイテッド | 遺伝子操作された免疫刺激性細菌菌株およびその使用 |
| JP7598315B2 (ja) * | 2018-09-05 | 2024-12-11 | エンエーセー オンコイミュニティ アクスイェ セルスカプ | 併用療法用ｄｎａワクチンを標的とするネオアンチゲン |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| US20230121528A1 (en) | 2020-01-13 | 2023-04-20 | Vaximm Ag | Salmonella-based dna vaccines in combination with an antibiotic |
| WO2024005122A1 (ja) * | 2022-06-30 | 2024-01-04 | 株式会社島津製作所 | 微生物の分析の準備方法、および、微生物の分析方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3892295T3 (pl) * | 2011-05-24 | 2023-07-24 | BioNTech SE | Zindywidualizowane szczepionki przeciwnowotworowe |
| CA2853656C (en) * | 2011-12-22 | 2020-12-29 | Vaximm Ag | Method of producing high yield attenuated salmonella strains |
| JP6325534B2 (ja) | 2012-07-05 | 2018-05-16 | バクシム アクチェンゲゼルシャフト | 膵臓癌患者用ｄｎａワクチン |
| MX364922B (es) * | 2013-04-25 | 2019-05-14 | Vaximm Ag | Vacuna de adn que dirige wt-1 novedosa para inmunoterapia contra cáncer. |
| SI3082850T1 (sl) * | 2013-12-18 | 2020-01-31 | Vaximm Gmbh | DNA cepivo, ki cilja MSLN za imunoterapijo raka |
| KR20230076867A (ko) * | 2013-12-20 | 2023-05-31 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
-
2017
- 2017-07-12 SG SG11201811258UA patent/SG11201811258UA/en unknown
- 2017-07-12 KR KR1020197002050A patent/KR20190027834A/ko not_active Ceased
- 2017-07-12 CA CA3028549A patent/CA3028549A1/en active Pending
- 2017-07-12 MX MX2019000415A patent/MX2019000415A/es unknown
- 2017-07-12 RU RU2019100079A patent/RU2019100079A/ru not_active Application Discontinuation
- 2017-07-12 EP EP17743277.0A patent/EP3484503A1/en active Pending
- 2017-07-12 KR KR1020237018125A patent/KR20230079514A/ko not_active Ceased
- 2017-07-12 CN CN201780043297.1A patent/CN109475614A/zh active Pending
- 2017-07-12 JP JP2019501917A patent/JP7098599B2/ja active Active
- 2017-07-12 WO PCT/EP2017/067590 patent/WO2018011289A1/en not_active Ceased
- 2017-07-12 AU AU2017295004A patent/AU2017295004B2/en active Active
- 2017-07-12 US US16/315,606 patent/US10821163B2/en active Active
- 2017-07-12 BR BR112019000657-5A patent/BR112019000657A2/pt not_active Application Discontinuation
- 2017-07-12 KR KR1020267008900A patent/KR20260047288A/ko active Pending
-
2018
- 2018-12-06 IL IL263568A patent/IL263568A/en unknown
-
2020
- 2020-09-29 US US17/037,627 patent/US11590215B2/en active Active
-
2022
- 2022-04-28 JP JP2022074854A patent/JP2022097591A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019521154A5 (https=) | ||
| Rechtien et al. | Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV | |
| RU2019100079A (ru) | Способ получения днк-вакцины для иммунотерапии рака | |
| IL299249B1 (en) | Genetically modified immune cells that include adapted shrna-microRNA (shrnamir) | |
| JP2022534282A5 (https=) | ||
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия | |
| Bolinger et al. | Adenoviral vector vaccination induces a conserved program of CD8+ T cell memory differentiation in mouse and man | |
| AU2018328220A1 (en) | Neoantigen identification for T-cell therapy | |
| CN111868080A (zh) | 利用泛等位基因模型进行的新抗原鉴别 | |
| CN104560864A (zh) | 利用CRISPR-Cas9系统构建的敲除IFN-β基因的293T细胞系 | |
| Malouli et al. | Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species | |
| CN105331635A (zh) | 一种诱导型慢病毒表达体系及其构建方法和应用 | |
| WO2020124830A1 (zh) | 基于人工串联启动子的枯草芽孢杆菌高效诱导表达系统 | |
| JP2019511218A5 (https=) | ||
| CN105132350B (zh) | 一种减毒鼠伤寒沙门氏菌的构建方法及其所得菌株和应用 | |
| Kistler et al. | Structural dynamics of Fusarium genomes | |
| Alharbi et al. | Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity | |
| JP2015507472A5 (https=) | ||
| CN104711240B (zh) | 禽呼肠孤病毒σA蛋白及其相关生物材料的应用 | |
| EP3159411B1 (en) | Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof | |
| CN113423724B (zh) | Ebv表位高亲和力t细胞受体 | |
| CN103957695A (zh) | 编码在黄麻中赋予疾病抗性的酶的核酸分子 | |
| JP2017029159A5 (https=) | ||
| CN104762274B (zh) | 禽呼肠孤病毒σNS蛋白及其相关生物材料的应用 | |
| Chen et al. | Multiple-copy-gene integration on chromosome of Escherichia coli for beta-galactosidase production |